All In MedTech

Device Trial Radar · NCT02146352

AXIOS Stent With Electrocautery Enhanced Delivery System

Last checked: Nov 20, 2026Latest source record: Oct 2, 2015 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

30

Actual

Start

Jun 2014

Primary completion

Jan 2015

Study completion Mar 2015

Sponsor

Lead sponsor
Xlumena, Inc.Not on our public-company list
Sponsor type
Industry
First posted
May 23, 2014

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to demonstrate the safety and effectiveness of the AXIOS Stent with Electrocautery Enhanced Delivery System for endoscopic transenteric drainage of pancreatic pseudocysts.

Conditions

  • Pancreatic Pseudocyst(s)

Interventions

  • AXIOS Stent with Electrocautery Enhanced Delivery SystemDevice

    Endoscopy with ultrasonography to implant AXIOS stent using electrocautery enhanced delivery system to allow drainage of pancreatic pseudocyst. Removal of AXIOS stent after 30 or 60 days.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety/Adverse Event Outcome Measure 1Time frame: Index procedure through 1-week post-stent removal

5 more outcomes with a free account

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • University of Colorado Denver

    Aurora, Colorado

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.